Company Directory / research

PrivateFor profitresearchAlachua, United Kingdom
Beacon Therapeutics is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.
Size
51-100 people: larger than 75% of companies with a size listed
Age
3 years old.
Reach
Website ranked #3,113,442 in the world for traffic, about 5k visits a month.
Health CareTherapeutics
Funding, as listed
$290M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Beacon Therapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Beacon Therapeutics received $170M in a Series B funding round to advance its eye disease gene therapy through late-stage trials. The company also entered a long-term partnership with Ascend for clinical and commercial AAV production.
Summaries written by the source dataset, not by us, and not checked.
research in United Kingdom.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.